spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  xenograft 

 HSMN NewsFeed - 29 Dec 2020
Collagen Matrix Acquires the GUIDOR(R) Synthetic Bone Graft & Membrane Business from Sunstar
Devices Acquisitions
 HSMN NewsFeed - 26 Dec 2019
OBI Pharma Granted FDA Orphan Drug Designation for the Treatment of Pancreatic Cancer for Its Antibody-Drug Conjugate (ADC) Targeted Cancer Therapy, OBI-999
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 13 Mar 2019
Hoth Therapeutics Enters into Commercial Licensing Agreement with University of Maryland, Baltimore and Isoprene Pharmaceuticals Inc.
Biopharmaceuticals Dermatology Licensing
 HSMN NewsFeed - 21 Nov 2018
OBI Pharma Granted FDA Orphan Drug Designation for OBI-888 for the Treatment of Pancreatic Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 6 Dec 2017
Sirnaomics' Leading siRNA Therapeutic Candidate, STP705, Granted Orphan Designation for Treatment of Cholangiocarcinoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 22 Jan 2016
Cellceutix Releases Data Used in Receiving FDA Orphan Drug Designation of Kevetrin for Pancreatic Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 15 Sep 2015
Molecular Response Appoints the Former Head of Translational Medicine Oncology at MedImmune/AstraZeneca, Brett Hall, Ph.D., as Chief Executive Officer
Diagnostics Personnel
 HSMN NewsFeed - 3 Sep 2014
ProNAi Therapeutics, Inc. Names New President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Nov 2013
3-V Biosciences Names Dr. William McCulloch Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Sep 2013
Champions Oncology Announces Two Additions to Senior Management Team
Biopharmaceuticals Personalized Medicine Personnel
 HSMN NewsFeed - 12 Jun 2013
RTI Biologics(R) Announces Agreement to Acquire Pioneer(R) Surgical Technology
Devices Orthopaedic Mergers & Acquisitions
 HSMN NewsFeed - 6 Jun 2013
RTI Biologics(R) Launches Fortiva(TM) Porcine Dermis, First Human Implantation Complete
Devices Surgery Product Launch
 HSMN NewsFeed - 10 Apr 2013
Lilly Debuts Early Oncology Pipeline Data At AACR Annual Meeting
Biopharmaceuticals Oncology
 HSMN NewsFeed - 13 Mar 2013
RTI Biologics(R) Receives 510(k) Clearance for Porcine Dermis Implant
Devices Surgery FDA
 HSMN NewsFeed - 28 Nov 2012
Curis Announces Worldwide In-Licensing of IAP Inhibitor GDC-0917 From Genentech
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 21 Nov 2012
OXiGENE Announces OXi4503 Granted Orphan Designation for Treatment of Acute Myelogenous Leukemia
Biopharmaceuticals Oncology
 HSMN NewsFeed - 26 Oct 2012
RTI Biologics(R) Announces Launch of BioReady(TM) DBM Putty
Devices Orthopaedic
 HSMN NewsFeed - 22 Jul 2011
Nils Bergenhem, PhD - Newly Appointed President and Chief Scientific Officer of Egenix, Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 May 2011
Lilly Presents Data on Cixutumumab in Five Subtypes of Sarcoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 15 Dec 2010
EpiCept Announces Initiation by NCI of Phase II Trial with Crolibulin(TM) in Anaplastic Thyroid Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 7 Sep 2010
RTI Biologics and Zimmer Dental Enter Distribution Agreement for Global Dental Biologic Implants
Devices Dental Distribution
 HSMN NewsFeed - 7 Sep 2010
Alethia Biotherapeutics Secures C$9.6 Million in Series A Financing to Fund Its Therapeutic Monoclonal Antibody Product Pipeline
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 14 Jul 2010
Aeterna Zentaris Announces Perifosine Has Received Orphan-Drug Designation for the Treatment of Neuroblastoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 7 Jun 2010
Immunomedics Reports Updated Results of Targeted Therapy for Advanced Pancreatic Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Mar 2010
RTI Biologics Launches Two Biologic Implants at Orthopaedic Surgeon Annual Meeting
Devices Orthopaedic
 HSMN NewsFeed - 4 Feb 2010
BioMarin to Acquire LEAD Therapeutics
Biopharmaceuticals Mergers & Acquisitions Oncology
 HSMN NewsFeed - 13 Jan 2010
RTI Biologics Adds Christie Blakely, Michael LaPrade to Leadership Team
Devices Orthopaedic Regenerative Medicine Personnel
 HSMN NewsFeed - 17 Nov 2009
Duke University Initiates Study of AEOL 10150 to Measure Compound's Ability to Protect Healthy Tissue in Mice Receiving Chemotherapy and Radiation for Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 21 Sep 2009
Brennen Medical Announces Sale of XenMatrix(R)
Devices Surgery Acquisitions
 HSMN NewsFeed - 14 Sep 2009
GENova Biotherapeutics prepares a 510(k) submission to the FDA
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 10 Sep 2009
Champions Biotechnology and PinnacleCare Enter Into Personalized Oncology Collaboration Agreement
Diagnostics Oncology Personalized Medicine
 HSMN NewsFeed - 20 Jul 2009
ImClone Systems and Bristol-Myers Squibb Announce Revisions to ERBITUX(R) (cetuximab) U.S. Product Labeling for Metastatic Colorectal Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 2 Mar 2009
ImClone Systems and Bristol-Myers Squibb Update Status of First-Line Squamous Cell Carcinoma of the Head and Neck Supplemental Biologics Application for ERBITUX(R) in U.S.
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 9 Feb 2009
RTI Biologics Announces Distribution and Supply Agreement with Aesculap for Biocleanse(R)-Sterilized Spinal Allografts
Devices Orthopaedic Neurosurgery Distribution
 HSMN NewsFeed - 23 Jan 2009
ImClone Systems and Bristol-Myers Squibb Update the Status of Non-Small Cell Lung Cancer Supplemental Biologics Application Submission for ERBITUX(R)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 8 Dec 2008
ERBITUX® Supplemental Biologics License Application for Advanced Non-Small Cell Lung Cancer Submitted to U.S. Food and Drug Administration
Biopharmaceuticals Oncology
 HSMN NewsFeed - 29 Oct 2008
ImClone Announces ERBITUX(R) Commercial Launch in Canada for Advanced Colorectal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 23 Oct 2008
OXiGENE, Inc. Names John A. Kollins as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Oct 2008
Study Published in New England Journal of Medicine Shows K-ras Gene Mutation Status May Affect Response to ERBITUX(R) Treatment
Biopharmaceuticals Oncology
 HSMN NewsFeed - 8 Oct 2008
Brennen Medical, LLC Launches XenMatriX(R) for Abdominal Wall (Hernia) Repair
Devices
 HSMN NewsFeed - 6 Oct 2008
Lilly to Acquire ImClone Systems in $6.5 Billion Transaction
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 19 Sep 2008
ERBITUX(R) Now Available in Japan for Use in Treating Patients with Advanced Colorectal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Sep 2008
ImClone Provides Update on Pivotal Phase 3 CRYSTAL Study in First-Line Metastatic Colorectal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 15 Sep 2008
Wright Medical Announces Launch of BIOTAPE XM(TM) Reinforcement Matrix
Devices Orthopaedic
 HSMN NewsFeed - 3 Sep 2008
ImClone Submits Supplemental Biologics License Application for ERBITUX(R) in First-Line Head and Neck Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 29 Aug 2008
ERBITUX(R) Phase 3 BMS-099 Lung Cancer Study Secondary Endpoint Update: Overall Survival Results Announced
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Jul 2008
ERBITUX(R) (Cetuximab) Receives Approval in Japan for Use in Advanced Colorectal Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 14 Jul 2008
ImClone Announces Changes in Commercial Organization Leadership
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Jun 2008
ImClone Appoints Dr. Bernhard Ehmer Senior Vice President and Managing Director, International Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Jun 2008
New Analyses of Pivotal Phase 3 Study of ERBITUX(R) Demonstrate Enhanced Efficacy in First-Line Metastatic Colorectal Cancer Patients with Wild-Type K-Ras Biomarker
Biopharmaceuticals Oncology
 HSMN NewsFeed - 31 May 2008
ERBITUX(R) (Cetuximab) Data Demonstrate Improved Overall Survival in First-Line Treatment of Advanced Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 May 2008
ERBITUX(R) (cetuximab) Data Demonstrate Improvements in Response Rate and Progression-Free Survival in Wild Type K-Ras Metastatic Colorectal Cancer Patients in First-Line Setting
Biopharmaceuticals Oncology
 HSMN NewsFeed - 15 May 2008
RTI Biologics Announces Successful Implantation of First Fresh-Stored Osteochondral Allograft
Devices Orthopaedic
 HSMN NewsFeed - 11 Apr 2008
Amrubicin is Designated as an Orphan Medicinal Product by the European Commission for the Treatment of Small Cell Lung Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 4 Mar 2008
Osteotech Receives FDA Clearance for Plexur M(TM) Biocomposite
Devices Regenerative Medicine Orthopaedic FDA
 HSMN NewsFeed - 27 Feb 2008
Regeneration Technologies, Tutogen Medical Merger Completed
Devices Mergers & Acquisitions
 HSMN NewsFeed - 25 Jan 2008
Over 30 New Studies of Oral Xeloda(R) Featured at the 2008 Gastrointestinal Cancers Symposium
Biopharmaceuticals Oncology
 HSMN NewsFeed - 17 Jan 2008
Regeneration Technologies, Tutogen Medical Announce New Name for Proposed Merged Company
Devices Mergers & Acquisitions
 HSMN NewsFeed - 3 Jan 2008
EntreMed Announces FDA Acceptance of IND Application for Aurora Kinase/Angiogenesis Inhibitor, ENMD-2076
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 20 Dec 2007
Human Genome Sciences and Aegera Therapeutics Announce Licensing and Collaboration Agreement on Novel Anti-Cancer Drugs
Biopharmaceuticals Licensing
 HSMN NewsFeed - 10 Dec 2007
GlaxoSmithKline and OncoMed Pharmaceuticals Form Strategic Alliance to Develop Cancer Stem Cell Antibody Therapeutics
Biopharmaceuticals Oncology
 HSMN NewsFeed - 29 Nov 2007
Published Data Suggest That ERBITUX(R) Enables Complete Surgical Resection of Colorectal Liver Metastases in Patients Previously Refractory to Conventional Systemic Therapy
Biopharmaceuticals Oncology
 HSMN NewsFeed - 14 Nov 2007
New England Journal of Medicine Study Shows ERBITUX(R) Improves Survival in Advanced Colorectal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 14 Nov 2007
Tutogen Medical, Inc. Announces New and Expanded Tissue Sourcing Agreements
Devices
 HSMN NewsFeed - 23 Oct 2007
Dr. David Sidransky Appointed Chairman of Champions Biotechnology, Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Sep 2007
Tutogen Medical, Inc. and Zimmer Holdings, Inc. Announce Agreement for International Distribution of Biological Products
Devices Distribution Dental
 HSMN NewsFeed - 4 Sep 2007
Zimmer and Tutogen Announce Agreement for International Distribution of Biological Products
Devices Distribution Dental
 HSMN NewsFeed - 28 Aug 2007
Wright Medical Group, Inc. Announces Launch of PRO-DENSE(TM) Injectable Regenerative Graft
Devices Orthopaedic
 HSMN NewsFeed - 12 Jul 2007
Regeneration Technologies Announces Launch of BioCleanse(R) Meniscus
Devices Orthopaedic
 HSMN NewsFeed - 12 Jul 2007
Agensys Raises $41 Million
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 2 Jul 2007
Mentor Announces Market Launch of NeoForm(TM) Dermis for Breast Reconstruction
Devices
 HSMN NewsFeed - 19 Jun 2007
OSI Pharmaceuticals Begins Clinical Development Program of OSI-906 in Patients with Advanced Solid Tumors
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 May 2007
Zimmer Holdings and Regeneration Technologies Enter Distribution Agreement for New Allograft Paste Implant
Devices Orthopaedic Neurosurgery Distribution
 HSMN NewsFeed - 9 May 2007
Tapestry Pharmaceuticals Announces Phase II Clinical Program for TPI 287
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Mar 2007
Tutogen Medical Names David C. Greenspan, Ph.D Vice President Global Research & Development
Devices Personnel
 HSMN NewsFeed - 20 Feb 2007
Tapestry Pharmaceuticals Appoints Sandra L. Silberman, M.D., Ph.D. As Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Feb 2007
Wright Medical Group and Regeneration Technologies Enter Agreement to Develop Advanced Biomaterial Implants for Foot and Ankle Surgeries
Devices Orthopaedic Regenerative Medicine
 HSMN NewsFeed - 8 Feb 2007
Osteotech Receives FDA Clearance for First Product Under Its Plexus Technology Platform
Devices
 HSMN NewsFeed - 17 Jan 2007
Molecular Insight Pharmaceuticals, Inc. Acquires Malignant Melanoma Radiotherapeutic Drug Candidate from Bayer Schering Pharma
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 17 Jan 2007
Cardiovascular Specialist Leman Cardiovascular(R) Announces Partnership Deal with Cook(R) Medical
Devices Surgery Cardiology
 HSMN NewsFeed - 27 Dec 2006
Tapestry Pharmaceuticals Appoints Donald H. Picker, Ph.D. As President
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Dec 2006
Regeneration Technologies Announces Manufacturing Agreement with Blackstone Medical for BioCleanse(R)-Sterilized Spinal Allografts
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 19 Dec 2006
Cryolife and Regeneration Technologies Enter Into Exchange and Service Agreement
Devices Regenerative Medicine
 HSMN NewsFeed - 19 Dec 2006
Regeneration Technologies, CryoLife Enter Into Exchange and Service Agreement
Devices Regenerative Medicine
 HSMN NewsFeed - 12 Dec 2006
INNOVIVE Pharmaceuticals Presents Data on Oncology Drug Programs in Chronic Myelogenous Leukemia and Acute Myelogenous Leukemia at American Society of Hematology 48th Annual Meeting
Biopharmaceuticals Oncology
 HSMN NewsFeed - 9 Nov 2006
Regeneration Technologies Announces Launch of Pre-Shaped Achilles Tendon Sterilized Through the BioCleanse(R) Process
Devices Orthopaedic
 HSMN NewsFeed - 31 Oct 2006
GammaCan International, Announces Appointment of Lynn Schuchter M.D. to its Scientific Advisory Board
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 30 Oct 2006
Regeneration Technologies Announces Domestic Implantation of BioCleanse(R)- Sterilized Sterling(R) Wedge
Devices
 HSMN NewsFeed - 24 Oct 2006
ProNAi Closes Successful Bridge Funding Round, Secures $6.65 Million Total
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 2 Oct 2006
EpiCept Announces IND Filing of Novel Compound with Potent Apoptotic and Tumor Selective Vascular Disruptive Activity for Treatment of Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 2 Oct 2006
Pioneer Surgical Technology Announces a New Agreement with Regeneration Technologies, Inc. to Distribute BioSet(TM) Demineralized Bone Matrix
Devices Orthopaedic Regenerative Medicine Distribution
 HSMN NewsFeed - 26 Sep 2006
ProNAi Announces Executive Team Buildup, Names New CEO and Top Development Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Sep 2006
Curis, Inc. Announces New Cancer Programs, Formation of China-Based Subsidiary
Biopharmaceuticals
 HSMN NewsFeed - 23 Aug 2006
PrimeCell(TM) Therapeutics Partners with Regeneration Technologies, Inc. to Co-Develop Stem Cell Product for Orthopedic Applications
Devices Orthopaedic Regenerative Medicine
 HSMN NewsFeed - 3 Aug 2006
Regeneration Technologies Begins Clinical Evaluation for Sterling(R) Implants Used in Spinal Surgeries
Devices Orthopaedic Regenerative Medicine
 HSMN NewsFeed - 1 Aug 2006
ArQule Announces Appointment of Nigel J. Rulewski as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 12 Jul 2006
Tigris Pharmaceuticals Completes License Agreements for the Exclusive Rights to Novel, Targeted Cancer Compounds
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 30 Jun 2006
Tutogen Medical Appoints Dr. Karl Koschatzky Managing Director
Devices Personnel
 HSMN NewsFeed - 29 Jun 2006
Tutogen Medical and Mentor Enter Into Exclusive Distribution Agreement for Breast Reconstruction Market
Devices Regenerative Medicine Distribution
 HSMN NewsFeed - 1 Jun 2006
Regeneration Technologies Receives CE Marks for Sterling(R) Implants Used in Spinal, Sports Medicine, General Orthopedic Surgeries
Devices Orthopaedic Regenerative Medicine Regulatory
 HSMN NewsFeed - 18 May 2006
RTI Holds Launch of Assembled Bone Tendon Bone Implant at AANA, AOSSM
Devices Orthopaedic
 HSMN NewsFeed - 13 Apr 2006
ArQule Announces Management and Board Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Apr 2006
New CPT and HCPCS J Codes Released from the American Medical Association and Centers for Medicare & Medicaid Services Relevant to OASIS(R) Wound Matrix and OASIS(R) Burn Matrix
Devices Wound Care Reimbursement
 HSMN NewsFeed - 30 Mar 2006
AVEO Pharmaceuticals Appoints John Ryan, Ph.D., M.D., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Mar 2006
Regeneration Technologies, Inc. Holds Launch of Sterling(R) Xenograft Line and BioSet(TM) DBM at AAOS
Devices Orthopaedic Regenerative Medicine
 HSMN NewsFeed - 20 Mar 2006
Sunesis Pharmaceuticals Initiates Phase II Clinical Trial of SNS-595 in Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 13 Mar 2006
Tutogen Medical, Inc. Contacted by Zimmer Holdings, Inc. to Discuss Potential Strategic Transactions
Devices
 HSMN NewsFeed - 9 Feb 2006
Tutogen Medical, Inc. Introduces New Soft Tissue Dental Product
Devices Dental Distribution
 HSMN NewsFeed - 7 Feb 2006
Tutogen Medical, Inc. Appoints L. Robert Johnston, Jr. Chief Financial Officer
Devices Personnel
 HSMN NewsFeed - 18 Jan 2006
Tutogen Medical, Inc. Completes Worldwide Distribution Agreement for Hernia Repair Tissues
Devices Surgery Distribution
 HSMN NewsFeed - 5 Jan 2006
AVEO Pharmaceuticals Acquires Rights to Novel Anti-Cancer Compound From Mitsubishi Pharma Corporation
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 4 Jan 2006
Sunesis Pharmaceuticals Initiates Phase II Clinical Trial of SNS-595 in Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology
Return to NewsFeed  

 Additional items found! 63

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 63 additional stories matching:
xenograft
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.